Search Results 281-290 of 14828 for anti-TNF drugs

  1. Anifrolumab-Fnia (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  2. Ustekinumab-Aekn (Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Selarsdi. Descriptions. Ustekinumab-aekn injection is used ...

  3. Publications - Saranya Chumsri, M.D. - Mayo Clinic

    ... Anti-TNF Therapy After COVID-19 Vaccination. Inflamm Bowel Dis. 2023 Aug 1; 29 (8):1202-1209. View PubMed; Chumsri S. Advancing outcomes of metastatic HER2 ...

  4. Genetic testing proves beneficial in prescribing effective blood thinners - Mayo Clinic News Network

    Anti-platelet drugs are given to prevent complications from blood clotting ... drug would benefit from the other anti-platelet medications. The meta ...

  5. Trihexyphenidyl (Oral Route) Description and Brand Names - Mayo Clinic

    Trihexyphenidyl is used alone or together with other medicines (e.g., levodopa) to treat Parkinson's disease. By improving muscle control and reducing stiffness ...

  6. Antithymocyte Globulin Rabbit (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  7. Kidney Transplant Program - Steroid-free immunosuppression protocols - Mayo Clinic

    Mayo Clinic doctors prescribe many types of immunosuppressive (anti-rejection) medications, which may include steroid-free immunosuppression protocols. In ...

  8. Tocilizumab-Aazg (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

    Tocilizumab-aazg injection is used alone or together with other medicines to treat moderate to severe active rheumatoid arthritis in patients who have been ...

  9. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

  10. Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    Demonstrated intolerance or inadequate response to one or more anti-tumor necrosis factor (TNF) therapies. Exclusion Criteria: Current diagnosis of ...